These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 25533429

  • 1. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.
    Ozel Coskun BD, Yucesoy M, Gursoy S, Baskol M, Yurci A, Yagbasan A, Doğan S, Baskol G.
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):142-9. PubMed ID: 25533429
    [Abstract] [Full Text] [Related]

  • 2. The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population.
    Yang MH, Sung J, Gwak GY.
    J Clin Lipidol; 2016 Feb; 10(2):289-98. PubMed ID: 27055959
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Feb; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 7. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Nadinskaia M, Maevskaya M, Ivashkin V, Kodzoeva K, Pirogova I, Chesnokov E, Nersesov A, Kaibullayeva J, Konysbekova A, Raissova A, Khamrabaeva F, Zueva E.
    World J Gastroenterol; 2021 Mar 14; 27(10):959-975. PubMed ID: 33776366
    [Abstract] [Full Text] [Related]

  • 8. Association of carotid intima media thickness with atherogenic index of plasma, apo B/apo A-I ratio and paraoxonase activity in patients with non-alcoholic fatty liver disease.
    Fadaei R, Meshkani R, Poustchi H, Fallah S, Moradi N, Panahi G, Merat S, Golmohammadi T.
    Arch Physiol Biochem; 2019 Feb 14; 125(1):19-24. PubMed ID: 29359590
    [Abstract] [Full Text] [Related]

  • 9. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY, Cho SY, Kim HJ, Kim SB, Song IH.
    J Clin Gastroenterol; 2014 Feb 14; 48(10):883-8. PubMed ID: 24440936
    [Abstract] [Full Text] [Related]

  • 10. Treatment of NASH with ursodeoxycholic acid: cons.
    Liechti F, Dufour JF.
    Clin Res Hepatol Gastroenterol; 2012 Sep 14; 36 Suppl 1():S46-52. PubMed ID: 23141894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between insulin resistance and apolipoprotein B in normoglycemic Koreans.
    Sung KC, Hwang ST.
    Atherosclerosis; 2005 May 14; 180(1):161-9. PubMed ID: 15823289
    [Abstract] [Full Text] [Related]

  • 14. Treatment of NASH with ursodeoxycholic acid: pro.
    Ratziu V.
    Clin Res Hepatol Gastroenterol; 2012 Sep 14; 36 Suppl 1():S41-5. PubMed ID: 23141893
    [Abstract] [Full Text] [Related]

  • 15. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.
    Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL.
    World J Gastroenterol; 2005 Apr 21; 11(15):2346-50. PubMed ID: 15818751
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heterogeneous responsiveness of normolipemic women to n-3 long chain fatty acid supplementation. Changes in serum lipids and apoproteins.
    Sánchez-Muniz FJ, Bastida S, Quintas E, Merinero MC, Rodríguez-Gil S.
    Rev Esp Fisiol; 1997 Dec 21; 53(4):349-54. PubMed ID: 9542772
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis.
    Kiyici M, Gulten M, Gurel S, Nak SG, Dolar E, Savci G, Adim SB, Yerci O, Memik F.
    Can J Gastroenterol; 2003 Dec 21; 17(12):713-8. PubMed ID: 14679419
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.